The rise in the prevalence of anxiety-related illnesses is increasing the demand for benzodiazepine APIs, which are often given to treat anxiety symptoms. Furthermore, ongoing study and development activities are targeted at increasing benzodiazepine administration and effectiveness.Wilmington, Delaware, United States, June 22, 2023 (GLOBE NEWSWIRE) -- In 2022, the benzodiazepine APIs market was estimated to be worth US$ 472.8 million. It is expected to grow at a 3.6% CAGR from 2023 to 2031, rea